tract in Biological Technology

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

... bacteria associated with respiratory tract infections, and, again in in vitro tests, it ... in the United States. CAP and other respiratory tract infections are caused by pathogens such as ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ...

Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies

... to infect and fuse with cells in the respiratory tract and cause disease. The new RSV-F vaccine ... responses to prevent infection of the respiratory tract and attack respiratory cells that may already be ... commonly identified cause of lower respiratory tract illnesses in infants and young children. ...

Angiotech announces positive results from Bio-Seal(TM) clinical study

... study results for its Bio-Seal(TM) Lung Biopsy tract Plug System at the Society of Interventional ... and distributor of the Bio-Seal Lung Biopsy tract Plug System, which has already received CE Mark ... in the EU. About BioSeal(TM) Lung Biopsy tract Plug System Bio-Seal is a novel technology ...

FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)

... (e.g., bronchitis and viral lower respiratory tract infections) in patients receiving SYMBICORT ... bronchitis, sinusitis and viral upper respiratory tract infection.(2) "Through these pivotal ... Safety Information Lower respiratory tract infections, including pneumonia, have been ...

NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate Directed Against the Fusion (F) Protein

... F protein to fuse with cells in the respiratory tract and cause illness. Novavax's RSV-F VLPs were ... commonly identified cause of lower respiratory tract infection in infants and young children with ... years of age) may also develop lower respiratory tract infections leading to bronchiolitis and ....

Addiction Treatment Finds Success Treating Brain Deficiencies through the Belly

... its effort to decrease toxic load, the body's GI tract inhibits absorption of many essential vitamins, ... now diagnoses the status of each patient's GI tract and repairs the body's ability to fuel itself as ... balance and repairs the malfunctioning GI tract to resolve the root cause of drug cravings and ...

Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results

... in the United States. CAP and other respiratory tract infections are caused by pathogens such ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ... bacteria associated with respiratory tract infections, and, again in in vitro tests, it ...

Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia

... in the United States. CAP and other respiratory tract infections are caused by pathogens such ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ... atypical organisms associated with respiratory tract infections. In in vitro tests, it appears to be ...

Advanced Life Sciences Announces Third Quarter 2008 Financial Results

... in the United States. CAP and other respiratory tract infections are caused by pathogens such ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ... oral antibiotic for the treatment of respiratory tract infections including CAP. For more information, ...

Advanced Life Sciences Announces Second Quarter 2008 Financial Results

... in the United States. CAP and other respiratory tract infections are caused by pathogens such ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ... bacteria associated with respiratory tract infections, and, again in in vitro tests, it ...

Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index

... bacteria associated with respiratory tract infections, and, again in in vitro tests, it ... in the United States. CAP and other respiratory tract infections are caused by pathogens such ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ...

Advanced Life Sciences Announces First Quarter 2008 Financial Results

... of thought leaders in the area of respiratory tract infections and antibiotic therapies to confirm ... in the United States. CAP and other respiratory tract infections are caused by pathogens such ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ...

Advanced Life Sciences Announces Fourth Quarter and Full Year 2007 Financial Results

... of thought leaders in the area of respiratory tract infections and antibiotic therapies; -- ... in the United States. CAP and other respiratory tract infections are caused by pathogens such ... the front-line treatments for respiratory tract infections such as CAP. As macrolide and ...

MedImmune Submits Biologics License Application to FDA for Motavizumab

... medically attended outpatient lower respiratory tract infections. Rates of adverse events, serious ... usually manifests as an upper respiratory tract infection with symptoms resembling a cold. ... of progressing to a serious lower respiratory tract infection that sometimes ...

Vapotherm(R) Announces Validation of U.S. Patent

... PATENT FOR APPARATUS AND METHOD FOR RESPIRATORY tract THERAPY STEVENSVILLE, Md., Jan. 22 ... in the delivery tube technology for respiratory tract therapy. Reinforcing Vapotherm's principal role ... helps deliver humidified air to the respiratory tract of patients. Used throughout all Vapotherm ...

FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections

... the treatment of complicated urinary tract infections. DORIBAX was effective against major ... following these procedures. Urinary tract infections (UTIs) account for at least 40% of ... infections, complicated urinary tract infections and nosocomial pneumonia, including ...

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

... were upper respiratory infection (20% CIMZIA, 13% placebo), urinary tract infection (7% CIMZIA, 6% placebo), and arthralgia (6% CIMZIA, 4% placebo). ... with placebo with concomitant methotrexate (n=324) were upper respiratory tract infection (6% CIMZIA, 2% placebo), headache (5% CIMZIA, 4% placebo), ...

Lilly Set to Unveil More Than 50 Studies at ASCO 2009

... on non-small cell lung cancer, breast cancer, cervical cancer and biliary tract cancer, among others, Lilly will demonstrate its continued commitment to ... or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): Results of a multicenter, randomized phase III trial (the UK ...

New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease

... ulceration associated with CD. Fistulas may originate from the intestinal tract or rectum and connect to the bladder, vagina, skin or other intestinal ... upper respiratory infection (20% CIMZIA (R) , 13% placebo), urinary tract infection (7% CIMZIA (R) , 6% placebo), and arthralgia (6% CIMZIA ...

Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)

... for other infections, in which the complex microbial make up of the GI tract is altered, and C. difficile spores may germinate, grow, and produce toxins A and B. The toxins cause damage to the GI tract lining in the colon, resulting in severe diarrhea, and may lead ...

Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA

... to be highly active against more than 500 community-acquired respiratory tract clinical isolates, including difficult-to-treat antibiotic-resistant ... contemporary (2008) bacteria isolated from community-acquired respiratory tract infections (CARTI), including oxacillin-resistant S. aureus (MRSA) (Poster ...

Advanced Life Sciences Announces Presentations at Fall Scientific and Investor Conferences and Third Quarter 2008 Earnings Conference Call

... will also sponsor a "Meet the Experts" series focused on respiratory tract pathogens and bacterial resistance led by infectious disease physicians ... NDA-stage once-a-day oral antibiotic for the treatment of respiratory tract infections including community acquired pneumonia. For more information, ...

MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease

... Synagis is indicated for the prevention of serious lower respiratory tract disease caused by RSV in children at high risk of RSV disease. Synagis ... is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients ...

Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic

... GanedenBC30 Probiotic is designed to survive and thrive in the digestive tract delivering ten times more probiotic cells than most yogurts. Immune and ... found in Sustenex(TM) survive and successfully colonize the intestinal tract where they can do the most good," said Davis. "Just like Omega 3s ...

Cure HIV Reaches Out to Foundation Community to Fund LiSAVIOR

... tract. HIV virus multiplies and mutates in the gastrointestinal tract and then is reabsorbed into the blood. This process is known to occur when ... of contaminated needles or during sexual intercourse. The gastrointestinal tract is comprised of the mouth and its structures, the pharynx, the esophagus, ...

Arpida Announces Full Year 2007 Financial Results

... that is being developed for the treatment of upper and lower respiratory tract infections contracted in the community setting. The compound is a novel ... advanced antibiotic programme, AR-709, targets upper and lower respiratory tract infections acquired in the community setting. AR-709 exhibited potent ...

Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis

... fibrosis (CF) suffer from chronic infections of the lower respiratory tract that can be caused by one or multiple bacteria, including Pseudomonas ... developed clinically for the aerosol treatment of chronic respiratory tract infections such as those found in cystic fibrosis patients. The company ...

MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results

... Keflex is indicated for treatment of the following infections: respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections. More information on Keflex and prescribing information are ...

Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial

... "In the case of MTP inhibition, Surface Logix viewed the gastrointestinal tract not as an obstacle, but as an ally in our quest for a viable therapeutic. ... of the triglyceride transport function of MTP in the gastrointestinal tract represents a significant opportunity for therapeutic intervention. About ...

NOLabs AB Achieves Break-Through in Fight Against MRSA-Bacteria

... time period. The main areas are prevention of catheter related urinary tract infections, relief of neuropathic pain and wound care products with an ... focus area is the prevention and treatment of catheter-associated urinary tract infections. NOLabs has developed the innovative, cost efficient and highly ...

Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis

... nasopharyngitis (inflammation of the nose and pharynx), upper respiratory tract infection and headache. More Information About Psoriasis Psoriasis is a ... herpes infections), candidiasis, bacterial infection (including urinary tract infections), upper respiratory infection, dizziness (including vertigo), ...

Advanced Life Sciences Announces Third Quarter 2007 Financial Results

... meetings, consisting of 10 thought leaders in the area of respiratory tract infections and antibiotic therapies. Business Outlook for the ... in late-stage clinical development for the treatment of respiratory tract infections. About Cethromycin Advanced Life Sciences is developing ...

Arpida Interim Results for six Months to 30 June 2007

... that is being developed for the treatment of upper and lower respiratory tract infections contracted in the community setting. In August 2006, the UK ... most advanced programme, AR-709, targets upper and lower respiratory tract infections acquired in the community setting. AR-709 exhibited potent ...

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

... patients after receiving allogeneic stem cell or bone marrow transplants. Similar to acute GVHD, there is also an inflammatory condition of the GI tract associated with cGVHD. Furthermore, acute GI GVHD occurs in approximately 60 percent of related donor and 70 percent of unrelated donor allogeneic ...

New Report Just Published: World Endoscopy Systems Market Report

... Cystoscopy II-29 Surgical Process II-29 Hernial Laparoscopy II-30 Ear, Nose and Throat (ENT) II-30 Laryngoscopy II-30 Respiratory tract II-30 Bronchoscopy II-30 Thoracic Laparoscopy II-31 Blebectomy II-31 Intubation Endoscopes II-31 Otoscopy II-31 Sinoscopy ...

Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment

... than or equal to 5 percent) for patients during the dose-optimization phase were decreased appetite, dry mouth, headache, insomnia, upper respiratory tract infection, irritability, nausea, anxiety, and feeling jittery. VYVANSE, which was introduced in the United States in July 2007 for the ...

Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply

... in the short term. About Hib Disease Haemophilus influenzae type b, or Hib, is a bacterium that resides in the upper respiratory tract of humans and is usually transmitted by coughing or sneezing. Invasive Hib disease can be very severe, and can cause hospitalization or even death. ...

Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock

... used in GanPro allows the bacteria to survive harsh manufacturing processes and the stomach environments of the animals to reach their digestive tract where they can grow creating the maximum benefit to the animal. "We're excited to enter the farming and livestock production industry with ...

AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule

... million men in the United States - but its etiology is far from being completely understood. Data from ongoing research suggest BPH and lower urinary tract symptoms (LUTS) are more complex conditions than once thought. While previous research on BPH etiology tended to focus on testosterone and other ...

AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia

... million men in the United States - but its etiology is far from being completely understood. Data from ongoing research suggest BPH and lower urinary tract symptoms (LUTS) are more complex conditions than once thought. While previous research on BPH etiology tended to focus on testosterone and other ...